Dr Sarah Wordsworth
|Tel||+44 (0)1865 289 268|
BSc MSc PhD
Associate Professor and University Research Lecturer
Sarah Wordsworth joined the Health Economics Research Centre in January 2003 and has developed a research programme within HERC on the economics of genetic and genomic technologies. Of particular interest are the economics of translating genomic high-throughput technologies from research into clinical practice, in both cancer and cardiovascular disease. In October 2006, Sarah took up a post-doctoral fellowship from the National Institute for Health Research. This fellowship involved methodological and applied research on the economic evaluation of novel genomic technologies in the NHS. Sarah's other interests include costing methodology and trial based evaluations in the areas of eye disease, blood transfusion, cardiac surgery and surgery for obesity. Prior to this appointment, Sarah worked in the Health Economics Research Unit at the University of Aberdeen from 1995-2002, after completing her MSc in Health Economics in 1995 at the University of York.
Design and implementation of the AIRWAYS-2 trial: A multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrest.
Taylor J. et al, (2016), Resuscitation, 109, 25 - 32
A Comparison of Health Professionals' and Patients' Views of the Importance of Outcomes of Bariatric Surgery.
Coulman KD. et al, (2016), Obes Surg, 26, 2738 - 2746
The cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial
Violato M. et al, (2016), BMJ Open
Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial
Stokes EA. et al, (2016), BMJ Open
A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
Reeves BC. et al, (2016), Health Technol Assess, 20, 1 - 260